Dupilumab improves aspirin tolerance in NSAID-exacerbated respiratory disease

14 days ago - By Healio

Following 6 months of dupilumab treatment, 57% of patients with NSAID-exacerbated respiratory disease had higher aspirin tolerance than before treatment, according to study results published in European Respiratory Journal.
These patients also had better smell perception and disease-specific quality-of-life measures, according to researchers.
“We demonstrated that treatment with dupilumab in patients leads to a significant reduction in polyp size accompanied by an improvement in quality of life and smell perception,” Sven Schneider,
Read more ...

  Tweet